Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-131,654
Closed -$3.69M – 761
2024
Q3
$3.69M Sell
131,654
-168,601
-56% -$4.76M 0.26% 97
2024
Q2
$7.85M Buy
300,255
+109,349
+57% +$2.27M 0.53% 45
2024
Q1
$4.18M Buy
190,906
+24,444
+15% +$524K 0.29% 59
2023
Q4
$3.87M Buy
166,462
+2,495
+2% +$50.2K 0.28% 54
2023
Q3
$3.24M Buy
163,967
+3,789
+2% +$74.6K 0.27% 69
2023
Q2
$3.63M Buy
160,178
+13,618
+9% +$274K 0.3% 66
2023
Q1
$2.88M Sell
146,560
-1,380
-0.9% -$26.5K 0.18% 124
2022
Q4
$2.54M Buy
+147,940
New +$2.62M 0.17% 148

Other funds holding RXO

Winton Group's RXO Position: Q4 2024 in Review

Winton Group sold out of RXO (RXO) in Q4 2024, closing a stake of 131,654 shares — an estimated $3.69M sold.

Winton Group first reported a position in RXO in Q4 2022 and held it in 8 quarters. The position peaked at $7.85M in Q2 2024. 279 funds tracked by Wall St. Rank hold RXO as of Q4 2024.

  • Winton Group reported no remaining RXO position as of Q4 2024 after selling out during the quarter.
  • Winton Group sold 131,654 RXO shares in Q4 2024, an estimated $3.69M.
  • Winton Group first reported a position in RXO in Q4 2022 and held it in 8 quarters.
  • Winton Group's RXO position peaked at $7.85M in Q2 2024.
  • 279 funds tracked by Wall St. Rank held RXO as of Q4 2024.

Based on Winton Group's 13F filing for Q4 2024, filed 12 Feb 2025.